Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip. A Comparison of Early Open Reduction Versus Late Open Reduction With Combined Pemberton and Femoral Osteotomies

NCT01133938 is registered in ClinicalTrials.gov with Orthopedic Hospital Vienna Speising as lead sponsor.

NCT NCT01133938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01133938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Factors for the Development of Osteonecrosis After the Treatment of the Developmental Dislocated Hip. A Comparison of Early Open Reduction Versus Late Open Reduction With Combined Pemberton and Femoral Osteotomies
Lead sponsor
Orthopedic Hospital Vienna Speising
Phase
Observational
Overall status
Completed
Start date
January 31, 2009
Completion date
May 31, 2010
Enrollment
79 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

predictors of osteonecrosis of the femoral head after treatment of the dislocated hip